You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-Androgen

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Transgender Women Trial in Pathum Wan (Estradiol, Estradiol and Anti-Androgen, No intervention)

Completed
  • Transgender Women
  • Estradiol
  • +2 more
  • Pathum Wan, Bangkok, Thailand
    Faculty of Sports Science, Chulalongkorn University
Nov 2, 2023

Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle

Active, not recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +7 more
  • Antiandrogen Therapy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022

Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial in Philadelphia

Recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • MRI-guided Intensity-Modulated Radiation Therapy
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 4, 2023

COVID-19, SARS-CoV2, Androgenetic Alopecia Trial in Brasilia (Proxalutamide, Standard of Care)

Completed
Has Results
  • COVID-19
  • +5 more
  • Brasilia, Brazil
    Corpometria Institute
Dec 8, 2021

Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,

Recruiting
  • Prostate Carcinoma
  • +6 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Metastatic Malignant Tumor in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7 Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in Lymph Node
  • +3 more
  • Antiandrogen Therapy
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Worldwide (drug, other, procedure)

Recruiting
  • Stage IV Prostate Adenocarcinoma AJCC v7
  • Antiandrogen Therapy
  • +5 more
  • Duarte, California
  • +15 more
Jan 24, 2023

PSA Level Greater Than 0.03, PSA Progression, Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7

Active, not recruiting
  • PSA Level Greater Than 0.03
  • +4 more
  • Antiandrogen Therapy
  • +2 more
  • Los Angeles, California
  • +1 more
Oct 14, 2021

Prostate Cancer Trial in Detroit, New York (Cabozantinib)

Recruiting
  • Prostate Cancer
  • Detroit, Michigan
  • +2 more
Mar 30, 2022

Efficacy After Anti-androgen Therapy for CRPC

Active, not recruiting
  • Castration Resistant Prostate Cancer (CRPC)
    • (no location specified)
    Jan 5, 2021

    Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)

    Recruiting
    • Salivary Gland Cancer
    • +3 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Feb 18, 2022

    Cancer of Prostate Trial in Belgium (Apalutamide, Leuprorelin Acetate 45Mg Powder for Injection Suspension Vial, Goserelin

    Recruiting
    • Cancer of Prostate
    • Aalst, Belgium
    • +8 more
    Aug 4, 2021

    Malignant Tumor Trial in United States (Ketoconazole, Laboratory Biomarker Analysis, Placebo Administration)

    Recruiting
    • Malignant Neoplasm
    • Danville, Illinois
    • +5 more
    Apr 13, 2022

    Metastatic Castration-resistant Prostate Cancer Trial (ONC-392, lutetium Lu 177 vipivotide tetraxetan 7.4 GBq (200 mCi), IV

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • ONC-392
    • lutetium Lu 177 vipivotide tetraxetan 7.4 GBq (200 mCi), IV infusion, Q6W for up to 6 doses.
    • (no location specified)
    Dec 27, 2022

    Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial

    Not yet recruiting
    • Locally Advanced Salivary Gland Carcinoma
    • +3 more
    • Biopsy
    • +3 more
    • (no location specified)
    Jan 10, 2023

    Pain, Opioid Use, Androgen Deficiency Trial in Boston (Testosterone Cypionate, Placebo)

    Recruiting
    • Pain
    • +2 more
    • Testosterone Cypionate
    • Placebo
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Apr 26, 2022

    Prostate Cancer Trial in Boston, Brooklyn, New York (225Ac-J591, Pembrolizumab, Androgen receptor pathway inhibitor)

    Recruiting
    • Prostate Cancer
    • Boston, Massachusetts
    • +3 more
    Sep 20, 2021

    Small Cell Neuroendocrine Carcinoma, Prostate Cancer, Small Cell Carcinoma Trial in San Francisco (Apalutamide, Cetrelimab)

    Recruiting
    • Small Cell Neuroendocrine Carcinoma
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Mar 21, 2022

    Prostate Cancer Trial (Radiation Therapy, Apalutamide, Luteinising Hormone Releasing Hormone analog agonist (LHRHa))

    Withdrawn
    • Prostate Cancer
    • Radiation Therapy
    • +3 more
    • (no location specified)
    Aug 13, 2020

    Prostate Cancer Trial in Philadelphia (drug, radiation, genetic)

    Active, not recruiting
    • Prostate Cancer
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Dec 7, 2020

    Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Detroit, Petoskey

    Completed
    • Stage I Prostate Adenocarcinoma
    • +2 more
    • Antiandrogen Therapy
    • +3 more
    • Detroit, Michigan
    • +2 more
    Oct 4, 2020

    Castration-Sensitive Prostate Carcinoma, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer Trial in Salt Lake City

    Terminated
    Has Results
    • Castration-Sensitive Prostate Carcinoma
    • +4 more
    • Abiraterone Acetate
    • +5 more
    • Salt Lake City, Utah
      Huntsman Cancer Institute/University of Utah
    Jun 5, 2020

    Congenital Uterine Anomalies & Pregnancy in Polycystic Ovarian

    Recruiting
    • Mullerian Anomaly of Uterus, Nec
    • Ultrasound and Hysterosalpingography
    • Bursa, Turkey
      Uludag University ART Center
    Feb 25, 2021

    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in New Brunswick, Portland

    Completed
    Has Results
    • Adenocarcinoma of the Prostate
    • +3 more
    • ipilimumab
    • laboratory biomarker analysis
    • New Brunswick, New Jersey
    • +1 more
    Sep 23, 2020

    Paraphilia Trial in Paris (behavioral, other, biological, genetic)

    Not yet recruiting
    • Paraphilia
    • Evaluation Scales
    • +4 more
    • Paris, France
      Hôpital Cochin
    Oct 31, 2022